Christos Papadimitriou

2008 University of Athens, Greece, Zografou, Greece 
"Christos Papadimitriou"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Apostolou P, Dellatola V, Papadimitriou C, et al. (2021) Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects. Cancers. 13
Fostira F, Papadimitriou M, Papadimitriou C. (2020) Current practices on genetic testing in ovarian cancer. Annals of Translational Medicine. 8: 1703
Apostolou P, Fostira F, Kouroussis C, et al. (2020) BRCA1 & BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects. International Journal of Cancer
Fountzilas E, Kotoula V, Koliou GA, et al. (2020) Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative. Oncotarget. 11: 1-14
Hardy-Bessard A, Moore KN, Mirza MR, et al. (2020) ENGOT-OV44/FIRST study: a randomized, double-blind, adaptive, phase III study of standard of care (SOC) platinum-based therapy ± dostarlimab followed by niraparib ± dostarlimab maintenance as first-line (1L) treatment of stage 3 or 4 ovarian cancer (OC). Journal of Clinical Oncology. 38
Koumarianou A, Makrantonakis P, Zagouri F, et al. (2020) Abstract P2-15-07: Real-world multicenter, prospective study of the effects of nab-paclitaxel on clinical outcomes and quality of life of patients with metastatic breast cancer in Greece. The ‘ABReast’ study Cancer Research. 80
Fountzilas E, Konstantopoulou I, Vagena A, et al. (2019) Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections. Clinical Breast Cancer
Fostira F, Kostantopoulou I, Apostolou P, et al. (2019) One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene. Journal of Medical Genetics
Vagena A, Papamentzelopoulou M, Kalfakakou D, et al. (2019) PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk. Journal of Human Genetics
Lampropoulou DI, Aravantinos G, Katifelis H, et al. (2019) Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer. Cancer Biomarkers : Section a of Disease Markers
See more...